Med Life SA · BVB:M
Med Life SA — Q1 2018 Earnings Presentation
9 slides from Med Life SA's earnings presentation, 2018
Slide 1: Conference Call Presentation for Q1 2018 Results
Conference Call Presentation for Q1 2018 Results
Slide 2: Legal Disclaimer
LEGAL DISCLAIMER This presentation is not, and nothing in it should be construed as, an offer, invitation or recommendation in respect of Med Life SA’s securities, or an offer, invitation or recommendation to sell, or a solicitation of an offer to buy Med Life SA’s securities. Neither this presentat
Slide 3: Topics of Discussion
TOPICS OF DISCUSSION I. KEY POINTS Q1 2018 4 II. MEDLIFE GROUP Q1 FINANCIAL SNAPSHOT 5 III. KEY OPERATIONAL METRICS FOR Q1 2018 7 IV. Q&A SESSION 8 Page 3
Slide 4: I. Key Points Q1 2018
I. KEY POINTS Q1 2018 Sales growth Q1 2018 vs Q1 2017: + 13.4% like2like 1 + 19.9% IFRS 2018 vs. IFRS 2017 + 34% Pro forma 2018 vs. IFRS 2017 EBITDA margin IFRS Q1 2017: 12.9% 2 EBITDA margin IFRS Q1 2018: 12.2% EBITDA margin Pro-forma Q1 2018: 12.4% 3 Net debt to EBITDA ratio of 3, after Polisano t
Slide 5: II. MedLife Group Q1 Financial Snapshot
II. MEDLIFE GROUP Q1 FINANCIAL SNAPSHOT Consolidated Statement of Financial Position Consolidated Statement of Profit and Loss Page 5
Slide 6: II. MedLife Group Q1 Financial Snapshot: OPEX Evolution
II. MEDLIFE GROUP Q1 FINANCIAL SNAPSHOT OPEX EVOLUTION Note: The Group recorded a 1.3 p.p. increase of operating expenses as % of sales in Q1 2018 as compared to Q1 2017. A. 0.6 p.p. decrease of “Consumable materials and repair materials” as % of Sales, generated by increased cost synergies and volu
Slide 7: III. Key Operational Metrics for Q1 2018
III. KEY OPERATIONAL METRICS FOR Q1 2018 Page 7
Slide 8: IV. Q&A Session
© Med Life IV. Q&A SESSION eo Ras Page 8
Slide 9: Thank You!
THANK YOU! © MedLife